BioMarker Pharmaceuticals

BioMarker's proprietary technology is based on identifying genes and proteins associated with aging and age-related diseases. By comparing differences in expression between animals and humans, as well as changes in gene and protein expression in models where aging has been slowed, BioMarker can pinpoint targets for the development of new anti-aging and disease-fighting therapies. Although we utilize a range of expression analysis techniques, much of our research focuses on our proprietary system, which is designed to develop products that mimic the effects of calorie restriction (CR) — the only intervention to date that consistently extends lifespan and delays aging in mammals.